Cargando…
The mitochondrial ATP synthase is a shared drug target for aging and dementia
Aging is a major driving force underlying dementia, such as that caused by Alzheimer's disease (AD). While the idea of targeting aging as a therapeutic strategy is not new, it remains unclear how closely aging and age‐associated diseases are coupled at the molecular level. Here, we discover a n...
Autores principales: | Goldberg, Joshua, Currais, Antonio, Prior, Marguerite, Fischer, Wolfgang, Chiruta, Chandramouli, Ratliff, Eric, Daugherty, Daniel, Dargusch, Richard, Finley, Kim, Esparza‐Moltó, Pau B., Cuezva, José M., Maher, Pamela, Petrascheck, Michael, Schubert, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847861/ https://www.ncbi.nlm.nih.gov/pubmed/29316249 http://dx.doi.org/10.1111/acel.12715 |
Ejemplares similares
-
The Role of Mitochondrial H(+)-ATP Synthase in Cancer
por: Esparza-Moltó, Pau B., et al.
Publicado: (2018) -
Regulation of the H(+)-ATP synthase by IF1: a role in mitohormesis
por: Esparza-Moltó, Pau B., et al.
Publicado: (2017) -
A comprehensive multiomics approach toward understanding the relationship between aging and dementia
por: Currais, Antonio, et al.
Publicado: (2015) -
The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice
por: Prior, Marguerite, et al.
Publicado: (2013) -
IF1 promotes oligomeric assemblies of sluggish ATP synthase and outlines the heterogeneity of the mitochondrial membrane potential
por: Romero-Carramiñana, Inés, et al.
Publicado: (2023)